The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Market Cap: $23.04 million Noxopharm is focused on discovering and developing novel treatments for cancer and inflammation.

Trailing total returns as of 2025-04-18, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) Return NOXOF S&P/ASX 200 [XJO] (^AXJO) ...

Leverage fair value analysis to evaluate the market value of stocks enabling more informed investment decisions.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...